ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

25.50
-1.94
(-7.07%)
終了 1月17日 6:00AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
25.50
買値
24.34
売値
27.45
出来高
98,749
25.01 日の範囲 27.45
24.61 52 週間の範囲 44.64
時価総額
前日終値
27.44
始値
27.29
最終取引時間
財務取引量
US$ 2,530,447
VWAP
25.625
平均取引量 (3 か月)
14,884
発行済株式数
1,916,787,029
配当利回り
18,260.41%
PER
0.24
1 株当たり利益 (EPS)
104.72
歳入
1.63T
純利益
200.73B

Daiichi Sankyo Co Ltd (PK) について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Biolog/vaccines
ウェブサイト
本社
Chuo, Tokyo, Jpn
設立
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the その他OTC with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$27.44. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 24.61 to US$ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares in issue. The market capitalisation of Daiichi Sankyo (PK) is US$52.60 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.24.

DSKYF 最新ニュース

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-2.24-8.0749819754927.7427.9524.612384425.46381746CS
4-4.15-13.996627318729.6529.824.611851026.96268014CS
12-4.86-16.007905138330.3634.7524.611488427.82559178CS
26-11.59-31.248314909737.0944.6424.61809129.4865901CS
52-6-19.047619047631.544.6424.611226530.93526082CS
1563.286114.792989974722.213944.6419.45875330.04862337CS
260-41.12-61.723206244466.6295.9617.61672129.7877769CS

DSKYF - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is US$ 25.50
How many Daiichi Sankyo (PK) shares are in issue?
Daiichi Sankyo (PK) has 1,916,787,029 shares in issue
What is the market cap of Daiichi Sankyo (PK)?
The market capitalisation of Daiichi Sankyo (PK) is USD 52.6B
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of US$ 24.61 to US$ 44.64 during the past year
What is the PE ratio of Daiichi Sankyo (PK)?
The price to earnings ratio of Daiichi Sankyo (PK) is 0.24
What is the cash to sales ratio of Daiichi Sankyo (PK)?
The cash to sales ratio of Daiichi Sankyo (PK) is 0.03
What is the reporting currency for Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) reports financial results in JPY
What is the latest annual turnover for Daiichi Sankyo (PK)?
The latest annual turnover of Daiichi Sankyo (PK) is JPY 1.63T
What is the latest annual profit for Daiichi Sankyo (PK)?
The latest annual profit of Daiichi Sankyo (PK) is JPY 200.73B
What is the registered address of Daiichi Sankyo (PK)?
The registered address for Daiichi Sankyo (PK) is 3-5-1 NIHONBASHI-HONCHO, CHUO-KU, CHUO, TOKYO, 103-8426
What is the Daiichi Sankyo (PK) website address?
The website address for Daiichi Sankyo (PK) is www.daiichisankyo.co.jp
Which industry sector does Daiichi Sankyo (PK) operate in?
Daiichi Sankyo (PK) operates in the PHARMACEUTICAL BIOLOG/VACCINES sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ZTNOZoom Technologies Inc (CE)
US$ 0.005
(499,900.00%)
500
DOMWFPrime Drink Group Corporation (PK)
US$ 0.1408
(20,014.29%)
13.14k
DLAPQDelta Apparel Inc (CE)
US$ 0.0002
(19,900.00%)
250
LCDXCaliber Imaging and Diagnostics Inc (CE)
US$ 0.02
(19,900.00%)
30.86k
FPPPFieldpoint Petroleum Corp (CE)
US$ 0.000134
(13,300.00%)
150
HTRCHunter Creek Mining Co (CE)
US$ 0.000005
(-99.99%)
2k
VAGNFVegano Foods Inc (CE)
US$ 0.000001
(-99.97%)
3.18k
NKWFFOceanic Wind Energy Inc (CE)
US$ 0.00002
(-99.93%)
1,000
HXPNHarris Exploration Inc (CE)
US$ 0.000001
(-99.92%)
8k
SEANSAEAN Group Inc (PK)
US$ 0.01
(-99.67%)
100
PHILPHI Group Inc (PK)
US$ 0.0003
(50.00%)
938.4M
RDARRaadr Inc (PK)
US$ 0.0012
(4.35%)
202.33M
RONNRonn Motor Group Inc (PK)
US$ 0.0004
(0.00%)
179.66M
HCMCHealthier Choices Management Corporation (PK)
US$ 0.00005
(4,900.00%)
170.84M
HMBLHUMBL Inc (PK)
US$ 0.00095
(-5.00%)
155.67M

最近閲覧した銘柄

Delayed Upgrade Clock